Fas apoptosis inhibitory molecule expression in B cells is regulated through IRF4 in a feed-forward mechanism

Journal of Immunology

Volumn 183, Issue 9, 2009, Pages 5575-5581

  Kaku, Hiroaki ^a   Rothstein, Thomas L ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; FAS APOPTOSIS INHIBITORY MOLECULE; INTERFERON REGULATORY FACTOR 4; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BAGG ALBINO MOUSE; BINDING SITE; CELL SELECTION; CHROMATIN IMMUNOPRECIPITATION; CLONING; GENE MUTATION; GERMINAL CENTER; MALE; MOUSE; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; RECEPTOR UPREGULATION; REGULATORY MECHANISM; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; B-LYMPHOCYTE SUBSETS; BASE SEQUENCE; CELL LINE, TUMOR; CELLS, CULTURED; CONSENSUS SEQUENCE; GERMINAL CENTER; INTERFERON REGULATORY FACTORS; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PC12 CELLS; PROMOTER REGIONS, GENETIC; RATS; UP-REGULATION;

EID: 77954159366     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901988     Document Type: Article

References (30)

1. Schneider, T. J., G. M. Fischer, T. J. Donohoe, T. P. Colarusso, and T. L. Rothstein. 1999. A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes. J. Exp. Med. 189: 949-956.
2. Zhong, X., T. J. Schneider, D. S. Cabral, T. J. Donohoe, and T. L. Rothstein. 2001. An alternatively spliced long form of Fas apoptosis inhibitory molecule (FAIM) with tissue-specific expression in the brain. Mol. Immunol. 38: 65-72.
3. Hemond, M., T. L. Rothstein, and G. Wagner. 2009. Fas apoptosis inhibitory molecule contains a novel β-sandwich in contact with a partially ordered domain. J. Mol. Biol. 386: 1024-1037.
4. Rothstein, T. L., J. K. Wang, D. J. Panka, L. C. Foote, Z. Wang, B. Stanger, H. Cui, S. T. Ju, and A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374: 163-165.
5. Foote, L. C., T. J. Schneider, G. M. Fischer, J. K. Wang, B. Rasmussen, K. A. Campbell, D. H. Lynch, S. T. Ju, A. Marshak-Rothstein, and T. L. Rothstein. 1996. Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells. J. Immunol. 157: 1878-1885.
6. Huo, J., S. Xu, K. Guo, Q. Zeng, and K. P. Lam. 2009. Genetic deletion of faim reveals its role in modulating c-FLIP expression during CD95-mediated apoptosis of lymphocytes and hepatocytes. Cell Death Differ. 16: 1062-1070.
7. Kaku, H., and T. L. Rothstein. 2009. FAIM enhances CD40 signaling in B cells and augments the plasma cell compartment. J. Immunol. 183: 1667-1674.
8. Sole, C., X. Dolcet, M. F. Segura, H. Gutierrez, M. T. Diaz-Meco, R. Gozzelino, D. Sanchis, J. R. Bayascas, C. Gallego, J. Moscat, et al. 2004. The death receptor antagonist FAIM promotes neurite outgrowth by a mechanism that depends on ERK and NF-κB signaling. J. Cell Biol. 167: 479-492.
9. Klein, U., S. Casola, G. Cattoretti, Q. Shen, M. Lia, T. Mo, T. Ludwig, K. Rajewsky, and R. Dalla-Favera. 2006. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat. Immunol. 7: 773-782.
10. Mittrucker, H. W., T. Matsuyama, A. Grossman, T. M. Kundig, J. Potter, A. Shahinian, A. Wakeham, B. Patterson, P. S. Ohashi, and T. W. Mak. 1997. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275: 540-543.
11. Frances, R., J. R. Tumang, and T. L. Rothstein. 2005. Cutting edge: B-1 cells are deficient in Lck: defective B cell receptor signal transduction in B-1 cells occurs in the absence of elevated Lck expression. J. Immunol. 175: 27-31. (Pubitemid 40884297)
12. Mizuno, T., and T. L. Rothstein. 2005. B cell receptor (BCR) cross-talk: CD40 engagement creates an alternate pathway for BCR signaling that activates IκB kinase/IκBα/NF-κB without the need for PI3K and phospholipase Cγ. J. Immunol. 174: 6062-6070.
13. Repetny, K. J., X. Zhong, N. E. Holodick, T. L. Rothstein, and U. Hansen. 2009. Binding of LBP-1a to specific immunoglobulin switch regions in vivo correlates with specific repression of class switch recombination. Eur. J. Immunol. 39: 1387-1394.
14. Lane, P., T. Brocker, S. Hubele, E. Padovan, A. Lanzavecchia, and F. McConnell. 1993. Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation. J. Exp. Med. 177: 1209-1213.
15. Francis, D. A., J. G. Karras, X. Y. Ke, R. Sen, and T. L. Rothstein. 1995. Induction of the transcription factors NF-κB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int. Immunol. 7: 151-161.
16. Mizuno, T., and T. L. Rothstein. 2003. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-κB. J. Immunol. 170: 2806-2810. (Pubitemid 36302149)
17. Kuo, T. C., and K. L. Calame. 2004. B lymphocyte-induced maturation protein (Blimp)-1, IFN regulatory factor (IRF)-1, and IRF-2 can bind to the same regulatory sites. J. Immunol. 173: 5556-5563.
18. Gongora, C., G. Degols, L. Espert, T. D. Hua, and N. Mechti. 2000. A unique ISRE, in the TATA-less human Isg20 promoter, confers IRF-1-mediated responsiveness to both interferon type I and type II. Nucleic Acids Res. 28: 2333-2341.
19. Greenwald, R. J., J. R. Tumang, A. Sinha, N. Currier, R. D. Cardiff, T. L. Rothstein, D. V. Faller, and G. V. Denis. 2004. Eμ-BRD2 transgenic mice develop B-cell lymphoma and leukemia. Blood 103: 1475-1484.
20. Chiles, T. C., and T. L. Rothstein. 1992. Surface Ig receptor-induced nuclear AP-1-dependent gene expression in B lymphocytes. J. Immunol. 149: 825-831.
21. Tamura, T., H. Yanai, D. Savitsky, and T. Taniguchi. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26: 535-584.
22. Honda, K., and T. Taniguchi. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6: 644-658.
23. Sciammas, R., A. L. Shaffer, J. H. Schatz, H. Zhao, L. M. Staudt, and H. Singh. 2006. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 25: 225-236.
24. Shen, Y., J. Iqbal, L. Xiao, R. C. Lynch, A. Rosenwald, L. M. Staudt, S. Sherman, K. Dybkaer, G. Zhou, J. D. Eudy, et al. 2004. Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs. BMC Immunol. 5: 20.
25. Elser, B., M. Lohoff, S. Kock, M. Giaisi, S. Kirchhoff, P. H. Krammer, and M. Li-Weber. 2002. IFN-γ represses IL-4 expression via IRF-1 and IRF-2. Immunity 17: 703-712.
26. Lu, R. 2008. Interferon regulatory factor 4 and 8 in B-cell development. Trends Immunol. 29: 487-492.
27. Muramatsu, M., V. S. Sankaranand, S. Anant, M. Sugai, K. Kinoshita, N. O. Davidson, and T. Honjo. 1999. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274: 18470-18476.
28. Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
29. Strasser, A., P. J. Jost, and S. Nagata. 2009. The many roles of FAS receptor signaling in the immune system. Immunity 30: 180-192.
30. Hennino, A., M. Berard, P. H. Krammer, and T. Defrance. 2001. FLICE-inhibitory protein is a key regulator of germinal center B cell apoptosis. J. Exp. Med. 193: 447-458.